Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Myers, C. Johnson (2007)
Management of Children With Autism Spectrum DisordersPediatrics, 120
N. Almandil, Y. Liu, M. Murray, F. Besag, K. Aitchison, I. Wong (2013)
Weight Gain and Other Metabolic Adverse Effects Associated with Atypical Antipsychotic Treatment of Children and Adolescents: A Systematic Review and Meta-analysisPediatric Drugs, 15
M. Murray, Y. Hsia, K. Glaser, E. Simonoff, D. Murphy, P. Asherson, Hanna Eklund, I. Wong (2013)
Pharmacological treatments prescribed to people with autism spectrum disorder (ASD) in primary health carePsychopharmacology, 231
T. Cadman, Hanna Eklund, D. Howley, H. Hayward, Hanna Clarke, James Findon, K. Xenitidis, D. Murphy, P. Asherson, K. Glaser (2012)
Caregiver burden as people with autism spectrum disorder and attention-deficit/hyperactivity disorder transition into adolescence and adulthood in the United Kingdom.Journal of the American Academy of Child and Adolescent Psychiatry, 51 9
Rebecca Rosenberg, David Mandell, Janet Farmer, J. Law, Alison Marvin, Paul Law (2010)
Psychotropic Medication Use Among Children With Autism Spectrum Disorders Enrolled in a National Registry, 2007–2008Journal of Autism and Developmental Disorders, 40
I. Wong, M. Murray (2005)
The potential of UK clinical databases in enhancing paediatric medication research.British journal of clinical pharmacology, 59 6
Carbone Carbone, Farley Farley, Do Do (2010)
Primary care for children with autismAmerican Family Physician, 81
G. Macarthur (2008)
Challenges and priorities for global mental health research in low- and middle-income countries. Symposium report.
T. Frazier, P. Shattuck, S. Narendorf, Benjamin Cooper, M. Wagner, E. Spitznagel (2011)
Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit/hyperactivity disorder.Journal of child and adolescent psychopharmacology, 21 6
Peter Lachmann (2000)
The Academy of Medical SciencesJournal of the Royal College of Physicians of London, 34
Fariz Rani, P. Byrne, M. Murray, P. Carter, I. Wong (2009)
Paediatric Atypical Antipsychotic Monitoring Safety (PAMS) StudyDrug Safety, 32
T. Charman, A. Pickles, E. Simonoff, S. Chandler, T. Loucas, G. Baird (2010)
IQ in children with autism spectrum disorders: data from the Special Needs and Autism Project (SNAP)Psychological Medicine, 41
E. Hollander, Ann Phillips, C. Yeh (2003)
Targeted treatments for symptom domains in child and adolescent autismThe Lancet, 362
S. Saxena, P. Sharan, B. Saraceno (2003)
Budget and financing of mental health services: baseline information on 89 countries from WHO's project atlas.The journal of mental health policy and economics, 6 3
M. Elsabbagh, G. Divan, Yun-Joo Koh, Y. Kim, S. Kauchali, Carlos Marcín, C. Montiel-Nava, V. Patel, C. Paula, Chongying Wang, M. Yasamy, E. Fombonne (2012)
Global Prevalence of Autism and Other Pervasive Developmental DisordersAutism Research, 5
J. Arden, L. Linford (2012)
Anxiety in Children and Adolescents
M. McPheeters, Z. Warren, Nila Sathe, Jennifer Bruzek, S. Krishnaswami, Rebecca Jerome, J. Veenstra-VanderWeele (2011)
A Systematic Review of Medical Treatments for Children With Autism Spectrum DisordersPediatrics, 127
The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines
S. Shea, A. Turgay, A. Carroll, M. Schulz, H. Orlik, I. Smith, F. Dunbar (2004)
Risperidone in the Treatment of Disruptive Behavioral Symptoms in Children With Autistic and Other Pervasive Developmental DisordersPediatrics, 114
E. Simonoff, A. Pickles, T. Charman, S. Chandler, T. Loucas, G. Baird (2008)
Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample.Journal of the American Academy of Child and Adolescent Psychiatry, 47 8
J. Zito, D. Safer, Lolkje Berg, K. Janhsen, J. Fegert, J. Gardner, G. Glaeske, S. Valluri (2008)
Child and Adolescent Psychiatry and Mental Health a Three-country Comparison of Psychotropic Medication Prevalence in Youth
D. Livermore, R. Reynolds, P. Stephens, G. Duckworth, D. Felmingham, Alan Johnson, S. Murchan, O. Murphy, U. Gungabissoon, P. Waight, R. Pebody, J. Shackcloth, M. Warner, L. Williams, R. George (2006)
Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors.International journal of antimicrobial agents, 28 4
S. White, D. Oswald, T. Ollendick, L. Scahill (2009)
Anxiety in children and adolescents with autism spectrum disorders.Clinical psychology review, 29 3
Assessment of the paediatric needs psychiatry
Rani Rani, Byrne Byrne, Cranswick Cranswick, Murray Murray, Wong Wong (2011)
Mortality in children and adolescents prescribed antipsychotic medication: A retrospective cohort study using the UK general practice research databaseDrug Safety: An International Journal of Medical Toxicology and Drug Experience, 34
G. Baird, E. Simonoff, A. Pickles, S. Chandler, T. Loucas, D. Meldrum, T. Charman (2006)
Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)The Lancet, 368
D. Mandell, K. Morales, S. Marcus, Aubyn Stahmer, J. Doshi, D. Polsky (2008)
Psychotropic Medication Use Among Medicaid-Enrolled Children With Autism Spectrum DisordersPediatrics, 121
Fariz Rani, P. Byrne, N. Cranswick, M. Murray, I. Wong (2011)
Mortality in Children and Adolescents Prescribed Antipsychotic MedicationDrug Safety, 34
(2008)
A three-country comparison of psy11
Philip Wang, S. Aguilar-Gaxiola, J. Alonso, M. Angermeyer, G. Borges, E. Bromet, R. Bruffaerts, G. Girolamo, R. Graaf, O. Gureje, J. Haro, E. Karam, R. Kessler, V. Kovess, M. Lane, Sing Lee, D. Levinson, Y. Ono, M. Petukhova, J. Posada-Villa, S. Seedat, J. Wells (2007)
Use of mental health services for anxiety, mood, and substance disorders in 17 countries in the WHO world mental health surveysThe Lancet, 370
N. Almandil, I. Wong (2011)
Review on the current use of antipsychotic drugs in children and adolescentsArchives of Disease in Childhood: Education & Practice Edition, 96
M. Kogan, S. Blumberg, L. Schieve, C. Boyle, J. Perrin, R. Ghandour, Gopal Singh, B. Strickland, E. Trevathan, P. Dyck (2009)
Prevalence of Parent-Reported Diagnosis of Autism Spectrum Disorder Among Children in the US, 2007Pediatrics, 124
I. Wong, M. Murray, D. Camilleri-Novak, P. Stephens (2004)
Increased prescribing trends of paediatric psychotropic medicationsArchives of Disease in Childhood, 89
Zito Zito, Safer Safer, Jong‐van den Berg Jong‐van den Berg, Janhsen Janhsen, Fegert Fegert (2008)
A three‐country comparison of psychotropic medication prevalence in youthChild and Adolescent Psychiatry and Mental Health, 2
Joanna Williams, Julian Higgins, C. Brayne (2005)
Systematic review of prevalence studies of autism spectrum disordersArchives of Disease in Childhood, 91
MacNeil MacNeil, Lopes Lopes, Minnes Minnes (2009)
Anxiety in children and adolescents with autism spectrum disordersResearch in Autism Spectrum Disorders, 3
J. Matson, D. Neal (2009)
Seizures and epilepsy and their relationship to autism spectrum disordersResearch in Autism Spectrum Disorders, 3
R. Owen, L. Sikich, R. Marcus, P. Corey-Lisle, G. Manos, R. Mcquade, W. Carson, R. Findling (2009)
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic DisorderPediatrics, 124
Rajesh Balkrishnan, Hemant Phatak, G. Gleim, S. Karve (2009)
Assessment of the use of angiotensin receptor blockers in major European markets among paediatric population for treating essential hypertensionJournal of Human Hypertension, 23
H. Faras, Nahed Ateeqi, L. Tidmarsh (2010)
Autism spectrum disordersAnnals of Saudi Medicine, 30
E. Bradley, P. Bolton (2006)
Episodic psychiatric disorders in teenagers with learning disabilities with and without autismBritish Journal of Psychiatry, 189
Application for inclusion to the 19th expert committee on the selection and use of essential medicines: Risperidone
(1994)
Diagnostic and statistical manual of mental diseases
R. Marcus, R. Owen, L. Kamen, G. Manos, R. Mcquade, W. Carson, M. Aman (2009)
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder.Journal of the American Academy of Child and Adolescent Psychiatry, 48 11
Y. Hsia, A. Wong, D. Murphy, E. Simonoff, J. Buitelaar, I. Wong (2013)
Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational studyPsychopharmacology, 231
D. Coury, E. Anagnostou, P. Manning‐Courtney, A. Reynolds, L. Cole, Robin Mccoy, A. Whitaker, J. Perrin (2012)
Use of Psychotropic Medication in Children and Adolescents With Autism Spectrum DisordersPediatrics, 130
K. Star, N. Iessa, M. Pharm, N. Almandil, B. Pharm, L. Wilton, S. Curran, I. Edwards, I. Wong (2012)
Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.Journal of child and adolescent psychopharmacology, 22 6
Rani Rani, Byrne Byrne, Murray Murray, Carter Carter, Wong Wong (2009)
Paediatric atypical antipsychotic monitoring safety (PAMS) study: Pilot study in children and adolescents in secondary‐ and tertiary‐care settingsDrug Safety: An International Journal of Medical Toxicology and Drug Experience, 32
R. Burke, A. Cardosi, A. Price, Alanna Teatom-Burke (2005)
The primary care of children with autism.Medicine and health, Rhode Island, 88 5
C. Lund, M. Tomlinson, M. Silva, A. Fekadu, R. Shidhaye, M. Jordans, I. Petersen, A. Bhana, F. Kigozi, M. Prince, G. Thornicroft, C. Hanlon, R. Kakuma, D. McDaid, S. Saxena, D. Chisholm, S. Raja, Sarah Kippen-Wood, S. Honikman, L. Fairall, V. Patel (2012)
PRIME: A Programme to Reduce the Treatment Gap for Mental Disorders in Five Low- and Middle-Income CountriesPLoS Medicine, 9
M. Souders, Thorton Mason, O. Valladares, M. Bucan, S. Levy, D. Mandell, T. Weaver, J. Pinto-Martin (2009)
Sleep behaviors and sleep quality in children with autism spectrum disorders.Sleep, 32 12
R. Reading (2011)
Review on the current use of antipsychotic drugs in children and adolescentsChild Care Health and Development, 37
Fariz Rani, M. Murray, P. Byrne, I. Wong (2008)
Epidemiologic Features of Antipsychotic Prescribing to Children and Adolescents in Primary Care in the United KingdomPediatrics, 121
M. Schlander (2008)
The NICE ADHD health technology assessment: A review and critiqueChild and Adolescent Psychiatry and Mental Health, 2
There is significant variation in prescriptions among countries in clinical practice for the treatment of comorbidities associated with autism spectrum disorder (ASD). It has been suggested that many people with mental health disorders in low‐/middle‐income countries do not receive adequate treatment. Hence, this study investigated psychopharmacological treatment patterns for ASD comorbidities in 30 countries and the association between country's income and prescription rates. The IMS Prescribing Insights database was used to investigate prescription patterns for ASD comorbidity treatment from 2007 to 2012. Data were obtained from 30 countries in continents of Europe, Asia, Oceania, Central America, South America, and Africa. The gross domestic product (GDP) per capita was used as a proxy for each country's income. Spearman correlation was used to examine the association between prescription rate and GDP per capita. The highest prescription rates were found in Western Europe (3.89–36.36/10,000) while the lowest prescription rates were found in Asian countries, such as Turkey, Indonesia, Saudi Arabia, and Pakistan (0.04–0.82/10,000). The most commonly prescribed drug for ASD comorbidity treatment in most of the countries was risperidone, but antidepressants and antiepileptic drugs were also frequently prescribed. There was a significant positive correlation between GDP per capita and prescription rate (Spearman ρ = 0.60; P = 0.0011; 95% confidence interval 0.27–0.81), that is, the higher the GDP per capita, the higher the prescription rate. There are marked international differences in prescription rates, and this is partially accounted by economic factors. Future research should combine more data for ASD comorbidity treatment to explore the disparity of psychopharmacological treatment between countries. Autism Res 2014, 7: 543–554. © 2014 International Society for Autism Research, Wiley Periodicals, Inc.
Autism Research – Wiley
Published: Oct 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.